Gabapentin
- Product NDC
- 43547-267
- 11-digit product format
- 435470267
- Labeler code
- 43547
- Product ID
- 43547-267_65acdb4c-8966-4fcd-ba81-69fea6473f25
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GABAPENTIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Solco Healthcare U.S., LLC
- Application
- ANDA090007
- Marketing category
- ANDA
- Marketing start
- 2012-10-15
- Marketing end
- 2020-09-01
- Substance
- GABAPENTIN
- Active strength
- 400 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 43547-267-03 | 2020-04-07 | C162847 | 48780-1 | 9d75b9d0-540a-f424-e053-dadaa90a57ce | 9e722109-1eef-40c2-8e93-46ef9fb42029 |
| 43547-267-10 | 2020-04-07 | C162847 | 48780-1 | 9d75b9d0-540a-f424-e053-dadaa90a57ce | 9e722109-1eef-40c2-8e93-46ef9fb42029 |
| 43547-267-50 | 2020-04-07 | C162847 | 48780-1 | 9d75b9d0-540a-f424-e053-dadaa90a57ce | 9e722109-1eef-40c2-8e93-46ef9fb42029 |
| 43547-267-03 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-540a-f424-e053-dadaa90a57ce | 9e722109-1eef-40c2-8e93-46ef9fb42029 |
| 43547-267-10 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-540a-f424-e053-dadaa90a57ce | 9e722109-1eef-40c2-8e93-46ef9fb42029 |
| 43547-267-50 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-540a-f424-e053-dadaa90a57ce | 9e722109-1eef-40c2-8e93-46ef9fb42029 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 43547-267-10 | EA - Each | 43547-267 | 07edeafe-0466-40f3-b218-ee5cb9ff8df0 | 1 | 2014-01-04 |
| 43547-267-50 | EA - Each | 43547-267 | 2ce57368-b96f-4fe1-b1ef-677852e27641 | 1 | 2014-01-04 |